Citius Oncology Income Statement (2022-2026) | CTOR

Income Statement Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Revenue & cost
Revenue (Quarter) 3.94M1.67M
Gross Profit (Quarter) 3.15M1.34M
Operating items
Research & Development (Quarter) 0.48M2.50M1.48M1.26M3.14M0.94M4.98M1.02M1.08M
Selling, General & Administrative (Quarter) 0.15M0.20M0.77M1.52M2.90M4.44M3.32M2.24M1.88M1.34M2.86M23.63M
Restructuring Costs (Quarter) 0.03M0.03M0.09M0.42M0.86M1.33M0.57M0.57M0.57M0.50M0.50M0.57M
Other Operating Expenses (Quarter) 2.16M3.02M6.65M1.24M1.52M1.56M-2.10M4.03M4.68M
Operating Expenses (Quarter) 0.18M0.23M0.86M4.58M9.27M13.90M6.39M7.47M4.94M4.71M8.41M29.95M
Operating Income (Quarter) -0.15M-0.20M-0.77M-0.27M-13.90M-6.39M-7.47M-4.94M-4.71M-5.25M-28.61M
EBIT (Quarter) -0.15M-0.20M-0.77M-4.55M-0.27M-13.90M-6.39M-7.47M-4.94M-4.71M-5.25M-28.61M
Non-operating items
Interest & Investment Income (Quarter) 0.03M0.04M
Non Operating Income (Quarter) 0.76M0.82M2.15M0.76M0.64M-0.02M1.77M
Net income details
EBT (Quarter) -0.15M-0.20M-4.81M-4.58M-9.27M-13.90M-6.39M-7.47M-5.11M-4.73M-5.27M-26.84M
Tax Provisions (Quarter) 0.14M0.29M0.43M0.26M0.26M0.26M0.26M0.26M-0.23M
Profit After Tax (Quarter) 0.61M0.62M1.39M-4.73M-9.56M-14.34M-6.66M-7.74M-5.37M-5.00M-5.53M-26.61M
Income from Continuing Operations (Quarter) -0.15M-0.20M-4.81M-4.73M-9.56M-14.34M-6.66M-7.74M-5.37M-5.00M-5.53M-26.61M
Consolidated Net Income (Quarter) -0.15M-0.20M-4.81M-4.73M-9.56M-14.34M-6.66M-7.74M-5.37M-5.00M-5.53M-26.61M
Income towards Parent Company (Quarter) -0.15M-0.20M-4.81M-4.73M-9.56M-14.34M-6.66M-7.74M-5.37M-5.00M-5.53M-26.61M
Net Income towards Common Stockholders (Quarter) -0.15M-0.20M-4.81M-4.73M-9.56M-14.34M-6.66M-7.74M-5.37M-5.00M-5.53M-26.61M
Additional items
EPS (Basic) (Quarter) -0.02-0.03-0.73-0.72-2.02-3.32-0.09-0.11-0.08-0.07-0.06-0.27
EPS (Diluted) (Quarter) -0.06-0.03-0.73-0.72-2.02-3.32-0.09-0.11-0.08-0.07-0.06-0.27
Shares Outstanding (Quarter) 1.87M6.60M6.60M6.60M6.60M4.74M4.31M68.05M71.55M71.55M71.55M73.27M87.46M100.03M
Shares Outstanding (Diluted) (Quarter) 1.34M2.42M6.60M6.60M6.60M4.74M4.31M68.05M71.55M71.55M71.55M73.27M87.46M100.03M
EBITDA (Quarter) -0.15M-0.20M-0.77M-4.55M-0.27M-13.90M-6.39M-7.47M-4.94M-4.71M-5.25M-28.61M
Interest Expenses (Quarter) 4.04M0.03M0.06M0.09M11.74M0.47M0.03M46.05M0.10M33.26M6.88M
Tax Rate (Quarter) -3.14-3.11-3.11-4.13-3.54-5.18-5.58-5.010.86